Compound Herba Speranskiae Tuberculatae and Boswellia carteri transdermal agent for treating Laogu bone diseases, and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of transdermal agent and old bone disease, which is applied in the field of compound frankincense transdermal agent for treating old bone disease and its preparation, can solve the problems of slow drug effect and poor drug absorption effect, and achieve definite curative effect, no toxic side effects, The effect of high social benefit and economic benefit
Inactive Publication Date: 2017-02-22
黑龙江德能理疗技术开发有限责任公司
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0007] The object of the present invention is to provide a compound frankincense transdermal agent for the treatment of old bone disease and its preparation method, which has various functions such as promoting blood circulation and tonifying kidney, strengthening muscles and bones, reducing inflammation and relieving pain, expelling wind and dampness, clearing heat and reducing swelling, etc. Cure cervical spondylosis, lumbar spondylosis, arthritis and other old bone diseases, and it effectively solves the problems of certain side effects of western medicine treatment in the prior art, slow drug effect and poor drug absorption effect of traditional Chinese medicine treatment; it has definite curative effect , The speed and efficiency of skin penetration are high, pure natural non-toxic side effects, small irritation and other advantages
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0042] A compound frankincense transdermal agent for treating old bone disease, comprising an emulsion matrix and a transdermal absorption accelerator, the mass ratio of the emulsion matrix and the transdermal absorption accelerator is 18:1; the emulsion matrix is composed of Chinese medicine extract , Emulsion raw material is constituted according to the mass ratio of 11:4; In the described Chinese medicine extract, each component is by weight, 290-310 parts of Sperancis fragrans, 90-110 parts of Olibanum, 80-90 parts of Herba Sinensis, 70-80 parts of pentagonal maple root, 70-80 parts of thousands of needles, 50-60 parts of strong rosette fern, 50-60 parts of small flower glass grass, 40-48 parts of eurya serrata, 40-45 parts of coriander 32-40 servings of Dayanguocao, 30-35 servings of orchid orchids in southern Yunnan, 25-30 servings of banyan root, and 25-30 servings of oxtail.
Embodiment 2
[0044] In the extract of the traditional Chinese medicine, the components are in parts by weight, 310 parts of Speranthum fragrans, 110 parts of frankincense, 85 parts of fenugreek, 75 parts of pentagonal maple root, 75 parts of thousands of needles and 55 parts of rosette fern. 55 parts of Liuli grass, 40 parts of Euphorbia serrata, 40 parts of coriander in western Hubei, 32 parts of Dayan pot grass, 30 parts of orchid orchid in southern Yunnan, 25 parts of banyan root, and 25 parts of oxtail.
Embodiment 3
[0046] In the extract of the traditional Chinese medicine, the components are in parts by weight, 300 parts of Speranthum frankincense, 100 parts of frankincense, 80 parts of fenugreek, 70 parts of pentagonal maple root, 70 parts of thousands of needles and 50 parts of rosette fern. , 50 parts of Liuli grass, 48 parts of Euphorbia serrata, 45 parts of coriander in western Hubei, 40 parts of Dayan pot grass, 35 parts of orchid orchid in southern Yunnan, 30 parts of climbing vine root, and 30 parts of oxtail.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a compound Herba Speranskiae Tuberculatae and Boswellia carteri transdermal agent for treating Laogu bone diseases, and a preparation method thereof. The transdermal agent comprises an emulsion matrix and a transdermal absorption promoter according to a mass ratio of 18:1; the emulsion matrix is formed by a traditional Chinese medicine extract liquid and an emulsion raw material according to a mass ratio of 11:4; the traditional Chinese medicine extract liquid comprises, by weight, 290-310 parts of Herba Speranskiae Tuberculatae, 90-110 parts of Boswellia carteri, 80-90 parts of Hedyotis tenelliflora, 70-80 parts of Chinese maple root, 70-80 parts of Stellaria yunnanensis, 50-60 parts of Angiopteris robusta Ching, 50-60 parts of Cynoglossum lanceolatum Forsk., 40-48 parts of Eurya nitida Korthals, 40-45 parts of Hydrocotyle wilsonii Diels ex Wolff, 32-40 parts of Carpesium macrocephalum Franch. Et Savat., 30-35 parts of Tuber of Satyrium henryi Schlecht., 25-30 parts of martin fig root and 25-30 parts of Smilax riparia A. DC.. The preparation method has the advantages of scientific, reasonable and effective preparation process, short process flow and low cost. The transdermal agent has the efficacy of invigorating blood circulation and tonifying kidney, strengthening tendons and bones, eliminating inflammation and relieving pains, dispelling wind and dampness, and clearing heat and eliminating swelling, and can effectively cure cervical spondylopathy, lumbar spondylosis, arthritis and other Laogu bone diseases.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine preparations, in particular to a compound frankincense transdermal agent for treating old bone disease and a preparation method thereof. Background technique [0002] Old bone disease is a general term for the following diseases, including: cervical spondylosis, lumbar spondylosis, hyperosteogeny, rheumatism, frozen shoulder, and sciatica. [0003] With the aging of the population and the changes in the way people live and work, the number of patients with old bone diseases is increasing, especially the spinal diseases are on the rise. According to the survey, 10-15% of adults suffer from cervical spondylosis, 60 - 80% of people have a history of low back pain. In other words, most people will be associated with spinal diseases sooner or later in their lives. [0004] Cervical spondylosis, also known as cervical syndrome, is a general term for cervical osteoarthritis, hypertrophic spo...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more